HeartSciences (HSCS) Cash from Investing Activities (QoQ) (2023 - 2025)
HeartSciences (HSCS) Cash from Investing Activities (QoQ) (2023 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | HeartSciences | 6.43 Mn | 4.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | -1,837.35% |
| Jul 31, 2025 | 89.58% |
| Apr 30, 2025 | 50.25% |
| Jan 31, 2025 | -168.76% |
| Oct 31, 2024 | -601.32% |
| Jul 31, 2024 | 98.80% |
| Apr 30, 2024 | -40.76% |
| Jan 31, 2024 | -2,419.52% |
| Oct 31, 2023 | 60.24% |
| Jul 31, 2023 | 35.33% |
| Apr 30, 2023 | -118.85% |